UNRESECTABLE PANCREATIC-CANCER - IS A MULTIMODALITY APPROACH A PROMISING THERAPEUTIC ALTERNATIVE

Background/Aims: The aim of this study was to evaluate the combination of immunochemotherapy and stop-flour upper abdominal chemotherapy in the prolongation of survival in patients with unresectable pancreatic cancer. Methodology: Thirty unresectable pancreatic cancer patients we re treated with immuno-chemotherapy in combination with stop-flow uppe r abdominal chemotherapy, in an atttempt to improve survival time. Res ults: The results obtained in. this study indicate that this hind of t reatment is feasible, safe and effective for patients suffering from S tage III and IV pancreatic duct carcinoma. Twenty per cent of the pati ents within this group were able to undergo radical resection and rema in alive and free of disease, with a mean survival rate of 16 months. Conclusion: The multi-modality approach used in this study achieved pr omising results for pancreatic cancer patients and is recommended as a promising therapeutic alternative.